News

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...
Eli Lilly (LLY) stock in focus as the company launches Mounjaro Kwikpen in India, intensifying competition with Novo ...
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
In 2024, Wegovy sales reached $8 billion, while Ozempic, its other Semaglutide product, brought in $17 billion. Lilly’s Mounjaro recorded $11.5 billion in global sales in 2024, an increase of 124% ...
The National Institute for Health and Care Excellence (Nice) said people finishing treatment through the NHS must receive ...
Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...
The National Institute for Health and Care Excellence (Nice) said people finishing treatment through the NHS must receive ...
Scientists are looking into alternative weight loss solutions beyond GLP-1 medications like Mounjaro, Ozempic and Wegovy ...
Lilly said in June it received approval from India’s drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo ...